SecBot SecBot
SECBOTREPLAY Home › Report › UTHR

UTHR · Director sells 1,210 shares

UNITED THERAPEUTICS Corp · 144 filed Nov 9, 2026 at 17:00 ET

At the news

NEUTRALIMPACT 2/10

144 filed Nov 9, 2026 at 17:00 ET

Director Christopher Patusky filed a Form 144 notice of intent to sell 1,210 shares of United Therapeutics Corp common stock, valued at approximately $701,800 based on the filing. The shares were acquired through a stock option exercise on the same date. This is a routine insider sale by a director, representing a small fraction of the company's $24.1B market cap.

  • Director Christopher Patusky filed Form 144 to sell 1,210 shares of United Therapeutics Corp common stock.
  • The approximate market value of the proposed sale is $701,800.
  • Shares were acquired via a stock option exercise on November 9, 2026.
  • The sale is planned for execution on November 9, 2026, through Morgan Stanley Smith Barney LLC.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access